Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
CVKD | US
-0.35
-7.45%
Healthcare
Biotechnology
30/06/2024
02/06/2026
4.35
4.71
4.72
4.14
Cadrenal Therapeutics Inc. operates as a clinical development biopharmaceutical company. The company focuses on developing Tecarfarin a novel therapy with orphan drug indication for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was incorporated in 2022 and is headquartered in Ponte Vedra Florida.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High 6-Month Volatility (>65%)
High Current Volume and Negative 1-Day Return
Microcap (<300M USD)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
60.0%1 month
60.7%3 months
95.1%6 months
114.0%-
-
5.11
0.00
0.00
0.21
-
-
-6.63M
5.14M
5.14M
-
-
-
-
-174.01
0.43
2.54
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
1.74
Range1M
2.85
Range3M
4.51
Rel. volume
2.39
Price X volume
678.37K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Galera Therapeutics Inc | GRTX | Biotechnology | 0.101 | 5.60M | 1.00% | n/a | -0.87% |
| Aptorum Group Limited | APM | Biotechnology | 0.976 | 5.34M | -8.79% | n/a | 13.53% |
| Xenetic Biosciences Inc | XBIO | Biotechnology | 3.38 | 5.21M | 2.11% | n/a | 0.00% |
| Alzamend Neuro Inc. Common Stock | ALZN | Biotechnology | 1.14 | 5.10M | -2.56% | n/a | 0.00% |
| Pulmatrix Inc | PULM | Biotechnology | 1.32 | 4.82M | -5.04% | n/a | 0.18% |
| Purple Biotech Ltd | PPBT | Biotechnology | 3.01 | 4.74M | 0.67% | n/a | 0.89% |
| NuCana plc | NCNA | Biotechnology | 2.07 | 4.65M | -4.61% | n/a | 0.00% |
| CollPlant Holdings Ltd | CLGN | Biotechnology | 0.4001 | 4.58M | -0.22% | n/a | 0.00% |
| SNTI | SNTI | Biotechnology | 0.9838 | 4.50M | 0.36% | n/a | 80.96% |
| PRFX | PRFX | Drug Manufacturers-Specialty & Generic | 2.02 | 4.50M | 0.00% | n/a | -2.89% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.71 | 4.37M | 1.18% | n/a | 17.32% |
| Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.0063 | 580.95K | 12.50% | n/a | -37.05% |
| Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 0.4821 | 265.64K | -11.54% | n/a | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 0.21 | - | Cheaper |
| Ent. to Revenue | - | - | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 5.11 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 95.11 | - | Riskier |
| Debt to Equity | 0.00 | -1.23 | Expensive |
| Debt to Assets | 0.00 | 0.25 | Cheaper |
| Market Cap | 5.14M | - | Emerging |